The Global MicroRNA (miRNA) Market: Size, Share & Trends Analysis (2018-2025) - Thermofisher Scientific, Agilent Technologies, Merck, Qiagen, and NanoString Technologies are Dominating - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 7, 2018--The “MicroRNA (miRNA) Market Size, Share & Trends Analysis Report By Research Tools, By Application (Cancer, Neurological Disease, Immunological Disorder, Infectious Diseases) By End-use, And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.The global microRNA (abbreviated miRNA) market size is expected to reach USD 626.27 million by 2025, posting a CAGR of 18.6% during the forecast period.A significant role of microRNAs in regulating gene expression. Their rapid adoption in development of diagnostic & prognostic tools for various cancer types is anticipated to provide a fillip to the market.
Recent innovations in miRNA applications such as their use as potential biomarkers in advanced diagnostics have accelerated new product development. Based on existing technologies used in gene analysis such as microarrays, qRT-PCR, and sequencing, new products are being developed for better usage of miRNA. These are designed to overcome challenges faced when working with miRNA.
Key FindingsGrowing competition among miRNA-based therapeutic companies to develop tests & biomarkers for clinical use is likely to boost the demand for miRNA detection services.Rapid high-quality results coupled with declining sequencing prices are poised to drive adoption of NGS services for miRNA functional studies.Some key companies present in the market are Thermofisher Scientific (Life Technologies); Agilent Technologies; Merck KGaA; QIAGEN (Exiqon); and NanoString Technologies Inc. The prominence of these players can be attributed to their well-established technical capabilities in other fields of biotechnology.Market Dynamics Drivers Recent Innovations in Applications of MiRNAsHigh Investments in MiRNA and Rising R&D Initiatives for Development of New Diagnostic Tests & TherapeuticsSuccess of MiRNA in Clinical TrialsTechnological Advancements to Support Nucleic Acid StudiesExponentially Declining Cost of Sequencing Restraints High Cost Associated With MicroRNA Kits and Other ProductsChallenges in Handling RNA & In-House Development of Assays for MicroRNA DetectionPoor Reproducibility of Research and Specificity of ProductsLimited Life Science Research Infrastructure in Emerging MarketsNeed of Skilled Personnel
Chapter 1 Executive Summary
Chapter 2 Research Methodology
Chapter 3 microRNA Market Variables, Trends& Scope
Chapter 4 microRNA Market: Products & Services Estimates & Trend Analysis
Chapter 5 microRNA Market: Application Estimates & Trend Analysis
Chapter 6 microRNA Market: End-use Estimates & Trend Analysis
Chapter 7 microRNA Market: Regional Estimates & Trend Analysis
Chapter 8 Competitive LandscapeMerck KGaAQIAGENDharmacon, a Horizon Discovery Group Co.Thermo Fisher Scientific, Inc.SynlogicGeneCopoeia, Inc.New England BiolabsQuantabioNanoString Technologies, Inc.BioGenexSeqMatic LLCMiltenyi BiotecSistemic Scotland LimitedBiodynamics Laboratory, Inc.OriGene Technologies, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/zl7rr7/the_global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005497/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/07/2018 08:04 AM/DISC: 11/07/2018 09:34 AM